Non-Small Cell Lung Cancer Therapy
Study findings on non-small cell lung cancer therapy are outlined in reports from C. Gridelli and colleagues
Published in Cancer Weekly, August 19th, 2008
Fresh data on non-small cell lung cancer are presented in the report 'The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients.' According to a study from Avellino, Italy, "Gemcitabine has been widely studied in elderly patients affected by advanced non-small cell lung cancer (NSCLC). A prolonged constant infusion (10 mg/m2/min) has been proposed as a way to improve its efficacy."
"Aim of this study is to describe activity and toxicity of single-agent gemcitabine given as prolonged infusion in the treatment of elderly patients with advanced NSCLC. Patients aged 70 years or older, with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-08-19)
More Articles from Cancer Weekly
- American Association for Cancer Research
Immunotherapy in high-risk pediatric sarcomas shows promising response - American College of Physicians
US Preventive Services Task Force updates prostate cancer screening recommendations - Cancer
Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results - Cancer
Study Shows Playing Video Games Can Change Behavior, Biology - Cancer Gene Therapy
New cancer gene therapy research reported from Medical College - Cancer Gene Therapy
Studies conducted at Kyushu University on cancer gene therapy recently published - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
